Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
The ACCURATE Study: Clinical Advancements in Genetic Testing for Familial Hypercholesterolemia in Acute Cardiac Care
FY 2023-24
Summary
The “Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE)” study aims to assess the utility of real-time genetic testing for diagnosing familial hypercholesterolemia (FH) in the medical care of young adults hospitalized with acute coronary syndrome (ACS). FH is a genetic disorder characterized by high levels of low-density lipoprotein cholesterol (LDL-C), which substantially increases the risk of coronary artery disease (CAD). FH affects approximately 1 in 300 individuals globally, but the vast majority of patients with FH remain undiagnosed. The ACCURATE study will test the hypothesis that genetic testing for FH in patients under 60 years admitted to hospital for ACS will improve the diagnosis and care of these patients. The primary outcome will be the number of newly diagnosed FH cases. Secondary outcomes include lipid-lowering medication usage, achieved LDL-C levels, adherence to lipid targets, and rates of cardiovascular events during the first year post-hospitalization. With a recruitment target of 250 patients, we anticipate a 25% increase in newly diagnosed FH cases, enabling timely intervention and reducing cardiovascular events. This research may unveil novel genetic variants associated with FH, enriching our understanding of the disease. This study will deliver a comprehensive dataset of genetic information, clinical outcomes, and the development and optimization of a next-generation sequencing panel for FH diagnosis. ACCURATE will lay the groundwork for establishing a province-wide clinical genetic testing program for FH.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506307
Name
Vaizman Nicol
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The ACCURATE Study: Clinical Advancements in Genetic Testing for Familial Hypercholesterolemia in Acute Cardiac Care
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Coronary Syndrome; Clinical Trial; Familial Hypercholesterolemia; Genetic Testing; Genomics; Lipid Disorders
Abstract
The “Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE)” study aims to assess the utility of real-time genetic testing for diagnosing familial hypercholesterolemia (FH) in the medical care of young adults hospitalized with acute coronary syndrome (ACS). FH is a genetic disorder characterized by high levels of low-density lipoprotein cholesterol (LDL-C), which substantially increases the risk of coronary artery disease (CAD). FH affects approximately 1 in 300 individuals globally, but the vast majority of patients with FH remain undiagnosed. The ACCURATE study will test the hypothesis that genetic testing for FH in patients under 60 years admitted to hospital for ACS will improve the diagnosis and care of these patients. The primary outcome will be the number of newly diagnosed FH cases. Secondary outcomes include lipid-lowering medication usage, achieved LDL-C levels, adherence to lipid targets, and rates of cardiovascular events during the first year post-hospitalization. With a recruitment target of 250 patients, we anticipate a 25% increase in newly diagnosed FH cases, enabling timely intervention and reducing cardiovascular events. This research may unveil novel genetic variants associated with FH, enriching our understanding of the disease. This study will deliver a comprehensive dataset of genetic information, clinical outcomes, and the development and optimization of a next-generation sequencing panel for FH diagnosis. ACCURATE will lay the groundwork for establishing a province-wide clinical genetic testing program for FH.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vaizman, Nicol
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~